News und Analysen
Chevron Starts Oil Production From Ballymore Project in Gulf of America
Chevron Corporation (NYSE: CVX) announced today that it started oil and natural gas production from the Ballymore subsea tieback in the deepwater Gulf of America. Ballymore, the latest in a series
American Express Delivers Strong First-Quarter Results With Revenue of $17.0 Billion, up 7%, or 8% on an FX-Adjusted Basis
American Express Company (NYSE: AXP) today reported first-quarter net income of $2.6 billion, or $3.64 per share, compared with net income of $2.4 billion, or $3.33 per share, a year ago.
ACIP Votes to Expand Recommendation for Pfizer’s RSV Vaccine ABRYSVO® to Include Adults Aged 50 to 59 at Increased Risk of Disease
Pfizer Inc. (NYSE: PFE) announced today that the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) voted to expand its recommendation for
Pfizer Provides Update on Oral GLP-1 Receptor Agonist Danuglipron
Pfizer Inc. (NYSE: PFE) today announced the decision to discontinue development of danuglipron (PF-06882961), an oral glucagon-like peptide-1 (GLP-1) receptor agonist, which was being investigated
Pfizer Invites Shareholders to Attend Virtual 2025 Annual Meeting of Shareholders on April 24
Pfizer Inc. (NYSE: PFE) announced today that its shareholders and the general public are invited to access its virtual 2025 Annual Meeting of Shareholders at 9:00 a.m. EDT on Thursday, April 24
ExxonMobil Announces Leadership Changes
ExxonMobil (NYSE: XOM) today announced Karen T. McKee, president of ExxonMobil Product Solutions Company and vice president Exxon Mobil Corporation, will retire effective May 1, 2025. The Board of
Advisory: Chevron Corporation’s 1Q 2025 Earnings Conference Call and Webcast
Chevron Corporation (NYSE: CVX), one of the world’s leading energy companies, will hold its quarterly earnings conference call on Friday, May 2, 2025, at 11:00 a.m. ET (10:00 a.m. CT).
Conference
European Commission Approves Pfizer’s RSV Vaccine ABRYSVO® to Help Protect Adults Aged 18-59 Against RSV Lower Respiratory Tract Disease
Pfizer Inc. (NYSE: PFE) announced today that the European Commission (EC) has issued a decision amending the marketing authorization for ABRYSVO®, the company’s bivalent respiratory syncytial virus
Chevron Announces Sale of Majority Interest in its East Texas Gas Assets
Chevron U.S.A. Inc., a subsidiary of Chevron Corporation (“Chevron”) (NYSE: CVX), announced that it has closed on a transaction to sell a 70% interest in its East Texas gas assets to an affiliate
American Express Plans Live Audio Webcast of First-Quarter 2025 Earnings Conference Call and Annual Meeting of Shareholders
As previously announced, American Express Company (NYSE: AXP) plans to host a live audio webcast of its earnings conference call at 8:30 a.m. (ET) on Thursday, April 17, 2025, to discuss
NIKE, Inc. Reports Fiscal 2025 Third Quarter Results
NIKE, Inc. (NYSE:NKE) today reported fiscal 2025 financial results for its third quarter ended February 28, 2025.
-
Third quarter revenues were $11.3 billion, down 9 percent on a reported basis
Pfizer Invites Public to View and Listen to Webcast of April 29 Conference Call with Analysts
Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10:00 a.m. EDT on Tuesday, April 29, 2025. The
Advisory: Chevron to Present at Piper Sandler 25th Annual Energy Conference
Eimear Bonner, Vice President and CFO of Chevron Corporation (NYSE: CVX), will take part in the Piper Sandler 25th Annual Energy Conference on Tuesday, March 18, 2025, at 11:00 AM ET (8:00 AM PT)
American Express to Acquire Expense Management Software Company Center
American Express (NYSE: AXP) today announced that it has entered into an agreement to acquire Center, a software company modernizing expense management.
This press release features multimedia
American Express Board Authorizes 17 Percent Dividend Increase
The Board of Directors of American Express Company (NYSE: AXP) has approved a $0.12, or 17 percent, increase in the quarterly dividend on the company’s common stock, consistent with the planned
Walmart Leadership to Participate in Upcoming Investor Events
Walmart Inc. (NYSE: WMT) announced today that company leadership will participate in upcoming investor events. Links to those with live webcasts can be found on Walmart’s investor relations website
Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
Pfizer Inc. (NYSE: PFE) invites investors and the general public to listen to a webcast of a discussion with Albert Bourla, Chairman and Chief Executive Officer, at the TD Cowen 45th Annual Health
Chevron Announces Senior Leadership Changes
Chevron Corporation (NYSE: CVX) today announced senior leadership changes as part of the company’s efforts to simplify its organizational structure, execute faster and more effectively, and be
NIKE, Inc. Announces Third Quarter Fiscal 2025 Earnings and Conference Call
NIKE, Inc. (NYSE: NKE) plans to release its third quarter fiscal 2025 financial results on Thursday, March 20, 2025, at approximately 1:15 p.m. PT, following the close of regular stock market
Walmart reports strong revenue of 4.1%, up 5.3% in constant currency (cc) with operating income growing faster at 8.3%, or 9.4% adjusted (cc)
Walmart Inc. (NYSE: WMT):
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250219052528/en/
Fourth Quarter Highlights:
-
Revenue of
Walmart Raises Annual Dividend 13 Percent to $0.94 Per Share, Marking 52nd Consecutive Year of Dividend Increases
The Board of Directors of Walmart Inc. (NYSE: WMT) approved an annual cash dividend for fiscal year 2026 of $0.94 per share. This represents a 13 percent increase from the $0.83 per share paid for
NIKE, Inc. Declares $0.40 Quarterly Dividend
NIKE, Inc. (NYSE: NKE) announced today that its Board of Directors has declared a quarterly cash dividend of $0.40 per share on the Company’s outstanding Class A and Class B Common Stock payable on
Pfizer’s TALZENNA® in Combination with XTANDI® Improves Survival Outcomes in Metastatic Castration Resistant Prostate Cancer
Pfizer Inc. (NYSE: PFE) today announced positive results from the Phase 3 TALAPRO-2 study of TALZENNA® (talazoparib), an oral poly ADP-ribose polymerase (PARP) inhibitor, in combination with XTANDI
Walmart To Host Fourth Quarter Earnings Conference Call February 20th, 2025
Walmart Inc. (NYSE: WMT) announced it will hold a live conference call with the investment community at 7 a.m. CST on Thursday, Feb. 20, 2025, to discuss the company's fourth quarter and full-year
U.S. FDA Approves Pfizer’s ADCETRIS® Combination Regimen for the treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (sBLA) for ADCETRIS® (brentuximab vedotin) in


